Visual Acuity

Lenz Therapeutics reported positive topline data from the phase 2 INSIGHT clinical trial investigating LNZ100 and LNZ101 for the treatment of presbyopia.

CHICAGO — Shelter-in-place orders used to mitigate the spread of COVID-19 decreased visual acuity improvements for patients with retinal detachments, according to a poster presented at the American Academy of Ophthalmology meeting.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Jennifer I. Lim, MD, discusses the year 1 and year 2 data for faricimab for the treatment of age-related macular degeneration and diabetic macular edema.

CHICAGO — A new diagnostic scale correlated with best corrected visual acuity and could serve as an alternative to evaluate disease activity in neovascular age-related macular degeneration, according to a study.

CHICAGO — Patients with dry age-related macular degeneration experienced sustained improvements in best correct visual acuity at month 13 of the LIGHTSITE III pivotal clinical trial, according to a study presented at Eyecelerator@AAO.

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Cathleen M. McCabe, MD, discusses trial data for Vuity in the correction of presbyopia.

The FDA announced that it cleared the Visibly Digital Acuity Product, a web-based, self-guided software application for testing visual acuity at home.

Participants with diabetic macular edema treated with a senolytic Bcl-xL inhibitor in the phase 2 BEHOLD study experienced visual acuity improvement after 18 weeks, according to a press release from Unity Biotechnology.

NEW YORK — Patients from an urban population who presented with advanced neovascular glaucoma had poor outcomes, according to a study.

NEW YORK — In this Healio Video Perspective from the ASRS meeting, Christopher R. Henry, MD, discusses results from a post hoc analysis of the phase 3 PEACHTREE study.